)
Edge20 Feb 2026
Dollar General: The Rural Retailer Playbook
How Dollar General built a small-box empire across rural America, scaling value and convenience into one of retail's most durable business models.
Marinomed Biotech
Marinomed Biotech (MARI) investor relations material
Marinomed Biotech GBC International Investment Forum summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.GBC International Investment Forum summary25 Feb, 2026
Company overview and business model
Focuses on solubilizing otherwise insoluble compounds, enabling new drug formulations.
Operates with a lean, efficient model, combining in-house and client-sponsored R&D projects.
Management and founders retain over 20% ownership, with significant free float and long-term seed investors.
Generates revenue through upfront, milestone, and royalty payments from both in-house and Solv4U client projects.
Recent restructuring completed, with profits from asset sales supporting future operations.
Lead assets and market potential
Budesolv, a solubilized nasal corticosteroid for allergic rhinitis, has completed phase III trials and is in partnering discussions.
Tacrosolv, a solubilized tacrolimus for inflammatory eye diseases, has shown efficacy in phase II and is also in advanced partnering talks.
Budesolv targets a double-digit billion USD market, aiming to address unmet needs with faster onset, lower dose, and preservative-free formulation.
Tacrosolv addresses a growing market for dry eye and inflammatory eye diseases, with the US market projected to reach $10 billion by 2030.
Both assets are protected by layered patents, maximizing exclusivity and value.
Commercialization and regulatory strategy
Budesolv's regulatory path clarified after resolving stability issues; Swiss approval expected to open access to multiple global markets.
Swiss registration could enable entry into Canada, UK, Singapore, Australia, New Zealand, Brazil, South Korea, MENA, and parts of Asia, covering up to 2 billion patients.
PK study planned for later this year, with Swiss market launch targeted for 2027.
Revenue generation expected from upfront and milestone payments before full regulatory approval.
Partnering is ongoing for Europe, Asia, MENA, and the US, with significant upfront payments anticipated.
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Marinomed Biotech earnings date
H2 202515 Apr, 2026
Marinomed Biotech
Next Marinomed Biotech earnings date
H2 202515 Apr, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Marinomed Biotech AG is an Austrian biotechnology company specializing in antiviral and immunology products. The company develops therapies based on proprietary technology platforms for treating respiratory and ocular diseases. It focuses on both prescription and over-the-counter formulations with applications in global healthcare markets. The company is headquartered in Korneuburg, Austria, and its shares are listed on the VSE.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage